Designed to access smaller, more fragile vessels with care and precision
Accessing small and fragile vessels is challenging. Having to worry if the catheter will have to be removed prematurely, and if you are protected should not add to the challenge. That is where the Neoflon™ Pro IV Cannula can help.
Based on the BD® Instaflash™ needle technology and using proprietary BD Vialon™ biomaterial, Neoflon™ Pro IV Cannula is designed to access smaller, more fragile vessels with care and precision; all that while protecting clinicians against needlestick injury.
The ergonomic design of this 24-G or 26-G cannula with its unique wing clip supports a familiar insertion technique for enhanced comfort and control.
Neoflon™ Pro IV Cannula incorporates the Instaflash™ needle technology, visually providing immediate feedback of successful vessel entry, which may reduce the number of insertion attempts.
Neoflon™ Pro IV Cannulas are made using proprietary Vialon™ biomaterial, which softens in the vein to enable longer dwell times,1* minimising restarts, and has clinically demonstrated to reduce the risk of phlebitis by up to 69% compared to fluorinated ethylene propylene (FEP)2 and up to 32% compared to polyurethane (PUR).3
Neoflon™ Pro Safety™ IV Catheter, an advanced version of Neoflon™ Pro IV Cannula, incorporates a passive needle shield technology that automatically covers the needle after cannulation, protecting against needlestick injuries.
Our powerful evidence-based assessments, with analytics and benchmarks, are the first phase of BD Vascular Access Management—and the first step on the path to enhance patient safety, workflow efficiency and cost-effectiveness across the entire patient journey.
Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.
Please consult BD product labels and inserts relevant to your geography for any indications, contraindications, hazards, warnings, cautions and instructions for use. Any discussion and/or content regarding BD products is limited to this information and instructions for use.
*Compared with an FEP catheter.
1. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845–854.
2. Kus B, Buyukyilmaz F. Effectiveness of Vialon biomaterial versus Teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020;e12328. https://doi.org/10.1111/jjns.12328.
3. Yasuda H, Rickard CM, Marsh N et al. Risk factors for peripheral intravascular catheter‑related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units. Annals of Intensive Care 2022; https://doi.org/10.1186/s13613-022-01009-5.
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
